RAPT Therapeutics, Inc.
NASDAQ:RAPT
1.17 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 5.288 | 0 | 0 | 0 | 0.641 | 0 | 0.886 | 0.641 | 0.756 | 0.966 | 0.869 | 1.222 | 1.302 | 1.528 | 1.277 | 0.935 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0.305 | 0.314 | 0.323 | 0.908 | 0.853 | 0.883 | 0.73 | 0.728 | 0.7 | 0.689 | 0.231 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | -0.305 | -0.314 | 4.965 | -0.908 | -0.853 | -0.883 | -0.089 | -0.728 | 0.186 | -0.048 | 0.525 | 0.966 | 0.869 | 1.222 | 1.302 | 1.528 | 1.277 | 0.935 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0.939 | 0 | 0 | 0 | -0.139 | 0 | 0.21 | -0.075 | 0.694 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 46.456 | 13.34 | 22.64 | 24.781 | 26.764 | 27.022 | 21.642 | 25.574 | 19.454 | 16.599 | 14.359 | 16.67 | 14.299 | 15.725 | 13.19 | 13.771 | 10.904 | 12.912 | 10.986 | 10.683 | 10.19 | 8.582 | 8.267 | 7.87 | 8.38 | 9.181 | 6.9 | 7.306 |
| General & Administrative Expenses
| 8.009 | 6.448 | 6.69 | 7.737 | 6.453 | 6.897 | 6.722 | 5.988 | 4.977 | 5.079 | 5.436 | 4.748 | 4.491 | 3.774 | 3.76 | 4.012 | 3.483 | 3.197 | 2.802 | 3.289 | 2.625 | 1.733 | 2.692 | 1.674 | 1.291 | 1.364 | 1.468 | 1.057 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | -0.314 | -0.323 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 8.009 | 6.448 | 6.69 | 7.423 | 6.13 | 6.897 | 6.722 | 5.988 | 4.977 | 5.079 | 5.436 | 4.748 | 4.491 | 3.774 | 3.76 | 4.012 | 3.483 | 3.197 | 2.802 | 3.289 | 2.625 | 1.733 | 2.692 | 1.674 | 1.291 | 1.364 | 1.468 | 1.057 |
| Other Expenses
| 0 | 0 | 0 | 1.997 | 2.341 | 2.548 | 3.084 | 2.291 | 1.48 | 0.443 | -0.275 | 0.309 | 0.105 | -0.118 | -0.029 | 0.047 | 0.549 | 0.237 | 0.391 | 0.135 | 0.259 | 0.344 | 0.333 | 0.356 | 0.241 | 0.261 | 0.164 | 0.132 |
| Operating Expenses
| 54.465 | 19.788 | 29.33 | 32.204 | 32.894 | 33.919 | 28.364 | 31.562 | 24.431 | 21.678 | 19.795 | 21.418 | 18.79 | 19.499 | 16.95 | 17.783 | 14.387 | 16.109 | 13.788 | 13.972 | 12.815 | 10.315 | 10.959 | 9.544 | 9.671 | 10.545 | 8.368 | 8.363 |
| Operating Income
| -54.465 | -19.788 | -29.33 | -32.518 | -33.217 | -33.919 | -28.364 | -31.562 | -24.431 | -21.678 | -18.909 | -20.777 | -18.034 | -18.533 | -16.081 | -16.561 | -13.085 | -14.581 | -12.511 | -13.037 | -12.815 | -10.315 | -10.959 | -9.544 | -9.671 | -10.545 | -8.368 | -8.363 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | -6.282 | 0 | 0 | 0 | -38.114 | 0 | -21.342 | -32.413 | -23.854 | -19.185 | -18.505 | -13.552 | -10.05 | -9.543 | -9.797 | -13.943 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 1.216 | 1.356 | 1.667 | 1.997 | 2.341 | 2.548 | 3.084 | 2.291 | 1.48 | 0.443 | -0.275 | 0.309 | 0.105 | -0.118 | -0.029 | 0.047 | 0.549 | 0.237 | 0.391 | 0.135 | 0.259 | 0.344 | 0.333 | 0.356 | 0.241 | 0.261 | 0.164 | 0.132 |
| Income Before Tax
| -53.249 | -18.432 | -27.663 | -30.521 | -30.876 | -31.371 | -25.28 | -29.271 | -22.951 | -21.235 | -19.184 | -20.468 | -17.929 | -18.651 | -16.11 | -16.514 | -12.536 | -14.344 | -12.12 | -12.902 | -12.556 | -9.971 | -10.626 | -9.188 | -9.43 | -10.284 | -8.204 | -8.231 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | -5.839 | 0 | 0 | 0 | -35.805 | 0 | -21.652 | -31.931 | -23.716 | -19.307 | -18.539 | -13.514 | -9.628 | -9.387 | -9.491 | -13.799 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0 | 0.271 | 2.885 | -0.325 | -0.269 | -2.291 | -1.48 | -0.443 | 0.275 | -0.309 | -0.231 | 0.029 | 0.056 | 0 | 0.199 | 0.287 | 0.267 | 0.237 | 0.66 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -53.249 | -18.432 | -27.663 | -30.521 | -30.876 | -31.371 | -25.28 | -26.98 | -21.471 | -20.792 | -19.459 | -20.159 | -17.929 | -18.651 | -16.11 | -16.514 | -12.735 | -14.631 | -12.387 | -13.139 | -13.216 | -9.971 | -10.626 | -9.188 | -9.43 | -10.284 | -8.204 | -8.231 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | -5.839 | 0 | 0 | 0 | -33.496 | 0 | -21.963 | -31.449 | -23.716 | -19.307 | -18.539 | -13.514 | -9.781 | -9.575 | -9.7 | -14.052 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.14 | -0.47 | -0.71 | -0.79 | -0.8 | -0.82 | -0.66 | -0.7 | -0.6 | -0.62 | -0.62 | -0.68 | -0.61 | -0.63 | -0.63 | -0.66 | -0.52 | -0.6 | -0.51 | -0.56 | -0.87 | -12.41 | -0.47 | -0.53 | -0.54 | -0.59 | -0.48 | -0.48 |
| EPS Diluted
| -1.14 | -0.47 | -0.71 | -0.79 | -0.8 | -0.82 | -0.66 | -0.7 | -0.6 | -0.62 | -0.62 | -0.68 | -0.61 | -0.63 | -0.63 | -0.66 | -0.52 | -0.6 | -0.51 | -0.56 | -0.87 | -12.41 | -0.47 | -0.53 | -0.54 | -0.59 | -0.48 | -0.48 |
| EBITDA
| -54.178 | -19.491 | -29.025 | -32.204 | -32.894 | -33.594 | -28.095 | -31.263 | -24.223 | -21.418 | -18.635 | -20.516 | -17.803 | -18.304 | -15.825 | -16.281 | -12.82 | -14.318 | -12.115 | -12.838 | -12.496 | -9.973 | -10.621 | -9.213 | -9.377 | -10.236 | -8.046 | -8.051 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | -6.22 | 0 | 0 | 0 | -38.114 | 0 | -21.033 | -32.006 | -23.854 | -18.948 | -18.211 | -13.323 | -10.05 | -9.37 | -9.797 | -13.73 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |